PULMONARY EMBOLISM RELATED REFRACTORY OUT-OF-HOSPITAL CARDIAC ARREST AND THE EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION: PRAGUE OHCA STUDY POST-HOC ANALYSIS. (YOUNG INVESTIGATOR AWARD COMPETITION)

BackgroundRefractory out-of-hospital cardiac arrest (r-OHCA) in patients with pulmonary embolism (PE) is associated with poor outcomes. The role of extracorporeal...

EXTRACORPOREAL MEMBRANE OXYGENATION IN THE THERAPY OF CARDIOGENIC SHOCK: ONE-YEAR OUTCOMES OF THE ECMO-CS TRIAL

Introduction: In the Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock (ECMO-CS) trial, immediate initiation of extracorporeal membrane oxygenation...

THE IMPACT OF CARDIOGENIC SHOCK AND OUT-OF-HOSPITAL CARDIAC ARREST ON THE OUTCOME OF ACUTE MYOCARDIAL INFARCTION. NATIONAL LEVEL ANALYSIS.

Background: Cardiogenic shock (CS) and out-of-hospital cardiac arrest (OHCA) are critical cardiovascular events with profound implications for patient outcomes. This...

IS ATRIAL FIBRILLATION A MARKER OF POOR PROGNOSIS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY? (YOUNG INVESTIGATOR AWARD COMPETITION)

IntroductionAtrial fibrillation (AF) is a common arrhythmia in patients with hypertrophic cardiomyopathy (HCM). Prognostic value of AF in HCM patients...

CLINICAL PREDICTORS OF LONG-TERM MORTALITY AFTER FIRST ABLATION OF VENTRICULAR TACHYCARDIA IN PATIENTS WITH STRUCTURAL HEART DISEASE

BackgroundCatheter ablation is a well-established treatment modality for a wide spectrum of ventricular tachycardias (VTs). However, in the presence of...

IDENTIFICATION OF PLASMATIC MARKERS PREDICTIVE OF LEFT VENTRICULAR RECOVERY IN RECENT-ONSET DILATED CARDIOMYOPATHY USING NON-TARGETED PROTEOMIC APPROACH: PILOT RESULTS (YOUNG INVESTIGATOR AWARD COMPETITION)

Introduction: Recent onset dilated cardiomyopathy (RODCM) represents a diagnostic and therapeutic challenge - some patients achieve complete recovery of left...

MORTALITY IN HYPERTROPHIC CARDIOMYOPATHY IS INDEPENDENT OF GENOTYPE

Background: Hypertrophic cardiomyopathy (HCM) patients with a pathogenic mutation are considered at greater risk of HCM-related adverse events (AE) than...

ASSOCIATION OF LEFT VENTRICULAR DILATATION PATTERNS WITH MORTALITY IN PATIENTS WITH MODERATE AND MODERATE-SEVERE AORTIC REGURGITATION

Background: Recent studies suggested that in Aortic Regurgitation (AR) volumetric measures may better reflect Left Ventricular (LV) remodeling than linear...

LONG-TERM FATE OF AN UNSELECTED COHORT OF CONGENITAL LONG QT SYNDROME PATIENTS DIAGNOSED IN CHILDHOOD

OBJECTIVES: Congenital long QT syndrome (LQTS) is genetically heterogeneous disorder with type-specific risk for major arrhythmic event (MAE). We performed...

THE R’’ WAVE IN V1 AND THE NEGATIVE TERMINAL QRS VECTOR IN AVF COMBINE TO A NOVEL 12-LEAD ECG ALGORITHM TO IDENTIFY SLOW CONDUCTING ANATOMICAL ISTHMUS 3 IN PATIENTS WITH TETRALOGY OF FALLOT

Aims: Patients with repaired tetralogy of Fallot (rTOF) have an increased risk of ventricular tachycardia (VT), with slow conducting anatomical...

INCREASED EXTRACELLULAR VOLUME IN THE VENTRICLES AFTER AORTIC VALVE REPLACEMENT IS NOT ASSOCIATED WITH A CHANGE IN CONDUCTION VELOCITY: A COMPUTATIONAL STUDY (YOUNG INVESTIGATOR AWARD COMPETITION)

Background: Extracellular volume (ECV) determined by magnetic resonance imaging (MRI) is considered a marker of diffuse myocardial fibrosis and a...

GDF-15 LEVEL CHANGES IN EARLY AND LATE PERIOD AFTER CATHETER ABLATION OF ATRIAL FIBRILLATION (YOUNG INVESTIGATOR AWARD COMPETITION)

Introduction: GDF-15 (growth differentiation factor 15) is protein from transforming growth factor β (TGF-β) cytokine family. In patients with atrial...

LONG-TERM OUTCOMES OF CONVERGENT ABLATION FOR PERSISTENT AND LONG-STANDING PERSISTENT ATRIAL FIBRILLATION

Single-stage hybrid radiofrequency ablation (hRFA) combines endoscopic epicardial and catheter endocardial ablation as a treatment for otherwise unsolvable long-term persistent...

MYOCARDIAL WORK IN VENTRICULAR PREEXCITATION (YOUNG INVESTIGATOR AWARD COMPETITION)

Background: Ventricular preexcitation alters electromechanical activation sequence and may induce left ventricular (LV) contractile discoordination and pathologic remodelling in selected...

LONG-TERM OUTCOMES OF PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS IMPLANTED IN CHILDHOOD: TRANSVENOUS VS. NONTRANSVENOUS SYSTEM

BACKGROUND: Implantable cardioverter-defibrillators (ICD) have been established as effective and safe therapy for prevention of sudden cardiac death in children....

CONDUCTION SYSTEM PACING PRESERVES BOTH ELECTRICAL AND MECHANICAL INTERVENTRICULAR SYNCHRONY – A UHF-ECG VALIDATION STUDY (YOUNG INVESTIGATOR AWARD COMPETITION)

Background:Interventricular mechanical delay (IVMD) is an established echocardiographic risk factor for pacing-induced cardiomyopathy development. Ultra-high-frequency ECG (UHF-ECG) is a non-invasive...

MARKERS OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE DECOMPENSATION

Introduction: Iron deficiency (ID) is one of the most common comorbidities in patients with heart failure (HF) regardless of the...

MID-TERM RESULTS OF A NEWLY INTRODUCED NATIONWIDE PEDIATRIC HEART TRANSPLANTATION PROGRAM

Background and Aim: Heart transplantation (HTx) is an effective treatment for terminal heart failure in children. Comprehensive pediatric nationwide HTx...

HOW INFERIOR VENA CAVA COLLAPSIBILITY INDEX FROM A NOVEL IMPLANTABLE SENSOR CORRELATES WITH ESTIMATED PLASMA VOLUME AND NT-PROBNP: A STUDY IN PATIENTS WITH CHRONIC HEART FAILURE

Background:A new wireless implantable sensor can measure inferior vena cava (IVC) area and collapsibility index and was invented for remote...

EFFECT OF STIMULATION FREQUENCY ON LEFT VENTRICULAR DYSSYNCHRONY IN HEART FAILURE PATIENTS TREATED WITH CARDIAC RESYNCHRONIZATION THERAPY

Background: Limited data exist that higher biventricular (BiV) pacing rate acutely reduces remaining left ventricular (LV) dyssynchrony in cardiac resynchronization...

WILL INTERMITTENT LEVOSIMENDAN ADMINISTRATION BRING BENEFITS IN ADVANCED HEART FAILURE?

Advanced heart failure (AdHF) is a clinical condition in which patients suffer from severe and persistent symptoms of heart failure....

ASSESSING LEFT VENTRICULAR FUNCTION BY GLOBAL LONGITUDINAL STRAIN ONE YEAR AFTER ST ELEVATION MYOCARDIAL INFARCTION

ObjectivesAim of this study was to explore changes in left ventricular global longitudinal strain (LV GLS) one year after STEMI...

EARLY DISCHARGE IN SELECTED ACUTE CORONARY SYNDROME PATIENTS AFTER INTERVENTIONAL TREATMENT: A SINGLE CENTER EXPERIENCE (YOUNG INVESTIGATOR AWARD COMPETITION)

Background: Utility of risk stratification in acute coronary sydrome (ACS) patients is well established. Efficient identification of low-risk patients may...

OUTCOMES OF PATIENTS WITH MYOCARDIAL INFARCTION AND CARDIOGENIC SHOCK TREATED WITH CULPRIT VESSEL-ONLY VERSUS MULTIVESSEL PRIMARY PCI.

Introduction and objectives. Multivessel primary percutaneous coronary intervention (pPCI) is still often used in patients with ST-elevation myocardial infarction (STEMI)...

CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND PRE-EXISTING LEFT HEART VALVULAR DISEASE

With aging population and rising prevalence of cardiovascular risk (CV) factors, the global number of patients with acute myocardial infarction...

CIRCADIAN DISRUPTION EXACERBATES CARDIAC INJURY FOLLOWING MYOCARDIAL INFARCTION

Circadian Disruption Exacerbates Cardiac Injury Following Myocardial Infarction

HRUDNÍ DRENÁŽ

VV ECMO

NEINVAZIVNÍ VENTILACE

UMĚLÁ PLICNÍ VENTILACE